P1318: THE IMPACT OF MELPHALAN DOSING IN COMBINATION WITH FLUDARABINE IN CLINICAL OUTCOMES OF PATIENTS WITH ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROMES RECEIVING ALLO-HCT

التفاصيل البيبلوغرافية
الحاوية / القاعدة:	HemaSphere
المؤلفون الرئيسيون:	O. Albanyan, D. Kalos, J. Kim, R. Faramand, H. Elmariah, A. Mishra, T. Nishihori, L. Perez, M. Nieder, J. Pidala, N. Bejnayan
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Wiley 2022-06-01
الوصول للمادة أونلاين:	http://journals.lww.com/10.1097/01.HS9.0000848136.92177.cc

مواد مشابهة

Fludarabine, busulfan, and melphalan conditioning regimen in allogeneic hematopoietic stem cell transplantation for adult patients with myeloid malignancies: A multicenter retrospective study
حسب: Jieling Jiang, وآخرون
منشور في: (2024-08-01)

FLUDARABINE-MELPHALAN-CAMPATH FOLLOWED BY UNMANIPULATED PERIPHERAL-BLOOD HAEMATOPOIETIC STEM CELLS CAN STILL CURE LYMPHOMA.
حسب: Daniele Avenoso, وآخرون
منشور في: (2023-06-01)

Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversity
حسب: Zachariah DeFilipp, وآخرون
منشور في: (2018-04-01)

Personalized prediction of overall survival in patients with AML in non‐complete remission undergoing allo‐HCT
حسب: Shigeki Hirabayashi, وآخرون
منشور في: (2021-07-01)

RIC VS MAC IN ALLO-HSCT FOR CHILDHOOD MYELODYSPLASTIC SYNDROME
حسب: Elena Morozova, وآخرون
منشور في: (2023-12-01)

sMAdCAM‐1 is decreased after allo‐HCT, along with gut microbiota dysbiosis, and is associated with hematopoietic recovery
حسب: Karen Fadel, وآخرون
منشور في: (2025-01-01)

BMT for Myelodysplastic Syndrome: When and Where and How
حسب: Akriti G. Jain, وآخرون
منشور في: (2022-01-01)

Fludarabine, cytarabine, and idarubicin with or without venetoclax in patients with relapsed/refractory acute myeloid leukemia
حسب: Rabia Shahswar, وآخرون
منشور في: (2023-07-01)

Fludarabine-melphalan as a preparative regimen for reduced-intensity conditioning allogeneic stem cell transplantation in relapsed and refractory Hodgkin’s lymphoma: the updated M.D. Anderson Cancer Center experience
حسب: Paolo Anderlini, وآخرون
منشور في: (2008-02-01)

A case report of fludarabine associated ectopic atrial bradycardia and literature review of fludarabine induced bradycardia
حسب: Steve Kong, وآخرون
منشور في: (2024-08-01)

P127 (0126) AUTOLOGOUS (AUTO-HCT) AND ALLOGENEIC STEM CELL TRANSPLANTATION (ALLO-HCT) IN THE MANAGEMENT OF RELAPSED/REFRACTORY (RR) HODGKIN LYMPHOMA (HL). A RETROSPECTIVE ANALYSIS OF THE LYMPHOMA WORKING PARTY OF THE EBMT
منشور في: (2018-10-01)

Successful treatment with fludarabine and cyclophosphamide in a VEXAS syndrome patient with associated myelodysplastic syndrome: a case report and systematic review
حسب: Polina Bellman, وآخرون
منشور في: (2024-04-01)

Enhancing myeloablative fludarabine-busulfan conditioning with total marrow irradiation in high-risk myeloid disease
حسب: Fernando Molina, وآخرون
منشور في: (2025-09-01)

ALL-RIC trial protocol: a comparison of reduced dose total body irradiation (TBI) and cyclophosphamide with fludarabine and melphalan reduced intensity conditioning in adults with acute lymphoblastic leukaemia (ALL) in complete remission
حسب: David I Marks, وآخرون
منشور في: (2023-06-01)

Le gouvernement d’Amanieu II, archevêque d’Auch (1261-1318)
حسب: Guillaume Terrasson
منشور في: (2025-07-01)

الشيخ عباس بن عليّ العِذَاريّ (ت 1318هـ) حياته وشعره
حسب: عباس هاني الجراخ, وآخرون
منشور في: (2021-07-01)

Comparison of pediatric allogeneic transplant outcomes using myeloablative busulfan with cyclophosphamide or fludarabine
حسب: Andrew C. Harris, وآخرون
منشور في: (2018-06-01)

Busulfan or Treosulfan Conditioning Platform for Allogeneic Stem Cell Transplantation in Patients Aged >60 Y With Acute Myeloid Leukemia/Myelodysplastic Syndrome: A Subanalysis of the GITMO AlloEld Study
حسب: Michele Malagola, MD, وآخرون
منشور في: (2023-03-01)

[18F]-Fludarabine for Hematological Malignancies
حسب: Louisa Barré, وآخرون
منشور في: (2019-04-01)

Allò mental, representació d'allò somàtic?
حسب: Octavi Fullat
منشور في: (1981-03-01)

The Role and Potential Therapeutic Application of Myeloid-Derived Suppressor Cells in Allo- and Autoimmunity
حسب: Qi Zhang, وآخرون
منشور في: (2015-01-01)

Reduced-toxicity conditioning with treosulfan and fludarabine in allogeneic hematopoietic stem cell transplantation for myelodysplastic syndromes: final results of an international prospective phase II trial
حسب: Tapani Ruutu, وآخرون
منشور في: (2011-09-01)

P1326: FACTORS ASSOCIATED WITH THE OUTCOME OF ALLO-HSCT FOR ADVERSE-CYTOGENETIC RISK ACUTE MYELOID LEUKEMIA
حسب: J. M. Cerezo-Martin, وآخرون
منشور في: (2022-06-01)

Preventive Use of Azacitidine in Patients with Acute Myeloid Leukemia after Haploidentical Allo-BMT
حسب: RSh Badaev, وآخرون
منشور في: (2018-12-01)

P539: PROGNOSTIC RELEVANCE OF MINIMAL RESIDUAL DISEASE IN THERAPY RELATED AND SECONDARY ACUTE MYELOID LEUKEMIA RECEIVING CPX-351 OR FLUDARABINE-BASED INDUCTION.
حسب: F. Guolo, وآخرون
منشور في: (2022-06-01)

WCN24-1318 The characteristics of IgM variant of proliferative glomerulonephritis with monoclonal immunoglobulin deposits
حسب: Lihong Bu, وآخرون
منشور في: (2024-04-01)

4FGL J1318.2+6754: A Long Orbital-period Redback Candidate
حسب: Jie Lin, وآخرون
منشور في: (2024-01-01)

TP53 Alterations in Myelodysplastic Syndromes and Acute Myeloid Leukemia
حسب: Ramy Rahmé, وآخرون
منشور في: (2023-04-01)

Busulfan and melphalan as conditioning regimen for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia in first complete remission
حسب: Nadjanara Dorna Bueno, وآخرون
منشور في: (2011-06-01)

Melphalan flufenamide inhibits osteoclastogenesis by suppressing proliferation of monocytes
حسب: Konstantin Byrgazov, وآخرون
منشور في: (2021-12-01)

Intravitreal Melphalan Chemotherapy for Vitreous Seeds in Retinoblastoma
حسب: Yacoub A. Yousef, وآخرون
منشور في: (2020-01-01)

Intravitreal and Subconjunctival Melphalan for Retinoblastoma in Transgenic Mice
حسب: Nisha V. Shah, وآخرون
منشور في: (2014-01-01)

In silico prediction of nonpermissive HLA-DPB1 mismatches in unrelated HCT by functional distance
حسب: Esteban Arrieta-Bolaños, وآخرون
منشور في: (2018-07-01)

Lower Number of Fludarabine Cycles in Patients with Lymphoid Malignancies
حسب: Donald Pasquale
منشور في: (2014-08-01)

Has the shortage of fludarabine altered the current paradigm of lymphodepletion in favor of bendamustine?
حسب: Dimitrios Filioglou, وآخرون
منشور في: (2023-11-01)

Giustizia allo specchio
حسب: Elisabetta Grande, وآخرون
منشور في: (2024-06-01)

Transformation of (allo)securinine to (allo)norsecurinine via a molecular editing strategy
حسب: Seoyoung Kim, وآخرون
منشور في: (2024-01-01)

Intravitreal Melphalan for Vitreous Seeds: Initial Experience in China
حسب: Xunda Ji, وآخرون
منشور في: (2016-01-01)

Melphalan intra-arterial chemotherapy for choroidal melanoma chemoreduction
حسب: Rodrigo Jorge, وآخرون
منشور في: (2022-08-01)

Ocular toxicity of intravitreal melphalan for retinoblastoma in Chinese patients
حسب: Kang Xue, وآخرون
منشور في: (2019-02-01)